Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weijer

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|April 29, 1998
Commentary: self interest is not the sole legitimate basis for making decisionsC Weijer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 1999
D'oh! An analysis of the medical care provided to the family of Homer J. SimpsonR Patterson, C Weijer
Oncology Nursing Forum|October 6, 1997
Do patients with breast cancer participating in clinical trials receive better nursing care?M Skrutkowska, C Weijer
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1994
The duty to exclude: excluding people at undue risk from researchC Weijer, A Fuks
BMJ (Clinical Research Ed.)|March 18, 1995
Pulling the plug on futilityC Weijer, C Elliott
The Journal of Clinical Ethics|January 14, 2000
Why should we include women and minorities in randomized controlled trials?C Weijer, R A Crouch
Science (New York, N.Y.)|September 2, 2000
Ethics. Protecting communities in biomedical researchC Weijer, E J Emanuel
NCEHR Communique = Communique CNERH|November 16, 2004
Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, CanadaJ A Anderson, C Weijer
Journal of Psychiatry & Neuroscience : JPN|November 1, 1996
Re: CCNP position paper on the use of placebos in psychiatryW C Friend, C Weijer
The Pharmacogenomics Journal|December 3, 2003
Protecting communities in pharmacogenetic and pharmacogenomic researchC Weijer, P B Miller
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|April 29, 1998
Commentary: self interest is not the sole legitimate basis for making decisionsC Weijer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 13, 1999
D'oh! An analysis of the medical care provided to the family of Homer J. SimpsonR Patterson, C Weijer
Oncology Nursing Forum|October 6, 1997
Do patients with breast cancer participating in clinical trials receive better nursing care?M Skrutkowska, C Weijer
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1994
The duty to exclude: excluding people at undue risk from researchC Weijer, A Fuks
BMJ (Clinical Research Ed.)|March 18, 1995
Pulling the plug on futilityC Weijer, C Elliott
The Journal of Clinical Ethics|January 14, 2000
Why should we include women and minorities in randomized controlled trials?C Weijer, R A Crouch
Science (New York, N.Y.)|September 2, 2000
Ethics. Protecting communities in biomedical researchC Weijer, E J Emanuel
NCEHR Communique = Communique CNERH|November 16, 2004
Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, CanadaJ A Anderson, C Weijer
Journal of Psychiatry & Neuroscience : JPN|November 1, 1996
Re: CCNP position paper on the use of placebos in psychiatryW C Friend, C Weijer
The Pharmacogenomics Journal|December 3, 2003
Protecting communities in pharmacogenetic and pharmacogenomic researchC Weijer, P B Miller
Pageof 7